A Cochrane review has found the surgical mesh implants which have so far been responsible for controversy and compensation claims to be "relatively safe".
However, the review is likely to be of little comfort to the many women who have suffered complications and injury as a result of the vaginal mesh implants, nor is it at this stage likely to have an impact on any of the outstanding compensation claims relating to mesh implants.
The implants are a medical device used to treat stress urinary incontinence (SUI), a condition which is thought to affect around 170,000 women in the United Kingdom.
Unfortunately, for the thousands of women who have received the trans-vaginal tape (TVT), there have been numerous reports of complications, including internal laceration, bleeding, pain during sex, implant erosion and perforation of the bladder and bowel.
Last month, concerns over the surgical mesh implants led Scottish health secretary Shona Robison to write to health boards asking them to suspend all mesh implant procedures pending the outcome of an independent inquiry, as well as a number of compensation claims.
Professor Cathryn Glazener of the University of Aberdeen, who helped carry out the Cochrane review, commented, "Overall the operations have been found to be relatively safe and relatively effective."
The independent review is due to be published in October of this year.
If you would like advice and information regarding your possible right to compensation following complications caused by a surgical mesh implant click through for more from Thompsons Solicitors, Scotland's leading personal injury solicitor firm.
